The research, led by Janet H. Van Cleave of UTHealth Houston Cizik School of Nursing together with colleagues across several institutions, examined survivorship care for head and neck cancer patients at a large academic health system in Southeast Texas. The system serves a thirteen-county catchment area that includes rural, suburban, and urban populations across fourteen academic and community hospitals, making it an ideal natural laboratory for asking whether geography shapes access to follow-up care. The team used two complementary methods. First, they surveyed fifteen clinicians and health system administrators involved in head and neck cancer care, asking them to rate how well their institution’s services matched the newly released National Standards for Cancer Survivorship Care. Second, they mined the electronic health records of 438 patients diagnosed between January 2022 and June 2024, counting every documented encounter in the first year after diagnosis.

The National Standards for Cancer Survivorship Care, developed in 2024 by the National Cancer Institute in partnership with the Department of Veterans Affairs and other federal agencies, organize survivorship care into three categories: policies, which define an organization’s capacity and structure; processes, which describe its ability to deliver care through embedded practices; and assessments, which measure the impact of that care. The survey asked participants to rate each standard on a four-point scale from not present to highly present, and the researchers converted these ratings into modified kappa scores, a statistical measure of agreement that corrects for chance. The results were revealing. Processes scored a respectable 0.60, indicating that clinicians perceived the system’s day-to-day delivery of survivorship services as reasonably well aligned with national expectations. Policies and assessments, by contrast, scored only 0.28 and 0.29 respectively, suggesting that the formal scaffolding needed to sustain and measure that care is far weaker.

Within those averages, individual standards told a more nuanced story. The highest-rated item, with a modified kappa of 0.93, was the assessment of risk for recurrence or new cancers, including family history and genetic testing with appropriate surveillance recommendations. Access to specialty services for managing late effects such as cardiovascular problems scored 0.87, and referrals to supportive services including nutrition, rehabilitation, and dental care scored 0.72. At the opposite extreme, the lowest-rated standard, a mere 0.07, was the collection of longitudinal data on survivors’ experiences and patient-reported outcomes. In other words, the institution excels at spotting cancer recurrence risk and connecting patients to specialists, but it has almost no systematic mechanism for learning whether its survivorship care actually works from the patient’s point of view.

The electronic health record analysis painted a different and partly contradictory picture. Across the 438 patients, who had a mean age of 64.5 years and were mostly male, White, and non-Hispanic, the researchers documented 4,233 encounters in the first year after diagnosis. Head and neck oncology care, meaning visits with surgeons, radiation oncologists, and medical oncologists, dominated with 76.5 percent of all encounters. The remaining quarter of care was concentrated almost entirely in two categories: specialist services, which accounted for 14.3 percent of encounters, and rehabilitation, which accounted for 6.0 percent. At the patient level, 38.8 percent had at least one specialist visit and 31.5 percent had at least one rehabilitation encounter. Strikingly, several services that are considered central to comprehensive head and neck cancer survivorship, including nutrition support, were completely undocumented in the record.

How can clinicians perceive a broad network of survivorship services while the data show only a narrow slice? The authors offer a compelling technical explanation. Electronic health records are built primarily for clinical care and billing, not for measuring the full spectrum of supportive services. A lymphedema assessment may be performed during a rehabilitation visit without ever appearing as a separate structured service category. Nutrition support may be delivered through patient education materials on websites or printed literature in waiting rooms, activities that generate no billable encounter and therefore leave no trace in the structured data. Clinicians, whose daily work involves actually delivering this care, may have a more complete picture of what patients receive than any database can capture. The discrepancy is not necessarily evidence of missing care; it is evidence that the measurement infrastructure is blind to much of what happens.

One of the most anticipated findings concerned geography. Prior research has suggested that rural patients face barriers to head and neck cancer care, since specialized surgery is concentrated in high-volume cancer centers that may require long travel. Yet in this study, residence in rural, suburban, or urban areas showed no association with the number of documented encounters. The cohort was well distributed geographically, with 36.5 percent urban, 28.8 percent suburban, and 33.8 percent rural residents, and a quarter living in areas with poverty rates of 20 percent or higher. The authors note that some studies have described a paradox of travel time, in which patients who travel farther to reach high-volume centers actually experience better outcomes, possibly because those who make the journey are a selected group. Disentangling whether encounter counts truly capture access, or whether geocoded travel distance tells a different story, remains an open question for future research.

What did predict how much care patients received? Comorbidity burden was the most consistent correlate. Each additional Charlson comorbidity was associated with a 13.0 percent higher rate of total encounters, a 9.1 percent higher rate of head and neck oncology visits, and a striking 46.4 percent higher rate of specialist encounters. Patients with more chronic disease generate more follow-up, which is clinically sensible but also hints that sicker survivors absorb a disproportionate share of limited survivorship resources. Rehabilitation encounters were the exception, showing no association with comorbidity count, and patients with laryngeal cancer trended toward fewer rehabilitation visits than those with oropharyngeal tumors. The authors caution that these observational findings should not be read causally, but they underscore how clinical complexity drives utilization patterns across the survivorship period.

The study’s limitations are worth noting. It was conducted at a single academic health system with an unusually integrated rehabilitation service, which may have inflated rehabilitation counts and limits generalizability. Care received outside the system was invisible, the quality of documented encounters could not be assessed, and structured coding may undercount services that were actually delivered. Still, the strengths are substantial: pairing provider perceptions with record-based utilization data offers a rare dual view of how survivorship standards are perceived, documented, and measured in a real system serving rural and urban populations alike. The authors point toward promising solutions, including natural language processing and large language model-assisted review of unstructured notes to detect care that structured fields miss, automated referral pathways, and digital symptom monitoring that could extend survivorship services into patients’ homes regardless of ZIP code.

The broader message resonates far beyond Southeast Texas. Head and neck cancer survivors face a formidable array of late effects, from dry mouth, swallowing difficulty, and pain to fatigue, lymphedema, dental problems, sleep disturbance, and emotional distress, and roughly a third experience emergency department visits or hospitalizations in their first year after diagnosis. The new national standards offer a blueprint, but this study shows that turning a blueprint into measurable, equitable care requires more than good intentions from clinicians. It requires policies that mandate documentation, assessments that capture patient-reported outcomes, and informatics infrastructure designed to see the full breadth of survivorship care rather than only its billable fragments. For the more than half a million Americans living after head and neck cancer, closing that visibility gap may be one of the most consequential steps the cancer care system can take.

Subject of Research: Alignment of head and neck cancer survivorship care with national survivorship standards across rural and urban patient populations

Article Title: Cancer survivorship care among head and neck cancer patients living in rural and urban locations

Article References: Van Cleave, J. H., Fortes, I. S. H., Rodriguez, J. A., Araya, A., Karni, R. J., Gutiérrez, C., Fenton, S. H., Schulman-Green, D., Myneni, S., Gong, Y., Jain, K. S., & Egleston, B. L. (2026). Cancer survivorship care among head and neck cancer patients living in rural and urban locations. Journal of Cancer Survivorship. https://doi.org/10.1007/s11764-026-02129-8

Image Credits: AI Generated

DOI: 10.1007/s11764-026-02129-8

Keywords: head and neck cancer, cancer survivorship, survivorship care standards, electronic health records, rural health, health services research, rehabilitation, comorbidity, health disparities, patient-reported outcomes, cancer care delivery, informatics

Cervical cancer continues to be the fourth most common cancer afflicting women worldwide, with staggering numbers recorded in 2020—over 600,000 new cases and 340,000 deaths globally. The disease disproportionately affects low- and middle-income countries, where structured cancer management systems are frequently challenged by infrastructural and logistical limitations. Tanzania, aligning itself with global efforts, adopted the NCTGs in 2020 to harmonize treatment protocols and enhance oncological outcomes for cervical cancer patients. However, bridging the gap between policy inception and effective implementation remains a formidable task.

The investigative team employed a qualitative case study approach at ORCI, Tanzania’s premier cancer treatment facility, to understand how institutional management shapes compliance with the newly established guidelines. Twenty healthcare professionals, strategically chosen for their comprehensive on-the-ground experience and intimate knowledge of cervical cancer treatment processes, participated in detailed interviews. These interviews were systematically recorded, meticulously transcribed, and translated from Swahili to English, ensuring accuracy and cultural context were preserved for analysis.

Central to the analysis was thematic coding—a rigorous qualitative method that examines narratives to uncover recurring patterns and themes. This approach illuminated several institutional factors pivotal to guideline uptake. Notably, the existence of explicit organizational policies governing guideline utilization emerged as a significant enabler. Such well-defined policies provide a structural backbone for clinical practice, ensuring that adherence is not left to individual discretion but embedded in the institutional fabric.

Another critical enabler identified was the presence of a supportive working environment. Healthcare providers underscored the importance of collaboration, mentorship, and open communication channels within the oncology department. An environment that nurtures professional growth and values adherence to best practices fosters a culture where guidelines are respected and systematically applied. This type of workplace atmosphere not only enhances morale but directly translates into improved patient care quality.

Complementary to these factors was the establishment of a well-coordinated support system within ORCI. This system includes standardized training modules, continual professional development opportunities, and administrative mechanisms to facilitate guideline implementation. The presence of these support structures demonstrates the institute’s commitment to translating policy into practice, ensuring that clinical staff are equipped to operationalize the NCTGs effectively.

Despite these positive institutional features, the study also unveiled substantial barriers impeding full compliance. Foremost among these is a critically low healthcare provider-to-patient ratio. The shortage of oncologists, surgeons, and auxiliary clinical staff strains the system, leading to overburdened personnel and compromised patient care pathways. The imbalance in workforce availability stands out as a systemic bottleneck that undermines even the most robust management frameworks.

Machine downtime was highlighted as another significant obstacle. In oncology care, diagnostic and therapeutic machinery—such as radiotherapy equipment—is central to delivering standardized treatment. Interruptions caused by technical failures or maintenance delays disrupt patient schedules, create treatment backlogs, and erode clinical consistency. These technological shortcomings compound workforce challenges, culminating in lapses in guideline adherence and diminished treatment quality.

The study’s findings underscore a compelling narrative: strong institutional management characterized by clear policies, supportive environments, and structured support systems creates fertile ground for guideline compliance. Nonetheless, structural constraints, particularly workforce shortages and infrastructural limitations, threaten to derail these gains. The duality reveals that policy precision and operational support must be harmonized with tangible resource investments to realize optimal cervical cancer care.

Within this context, the researchers advocate for urgent collaborative efforts between Tanzania’s Ministry of Health and ORCI management to prioritize workforce expansion. Recruiting additional oncologists, surgeons, nurses, and allied health professionals is paramount to elevating the provider-to-patient ratio to sustainable levels. Such staffing reinforcements would alleviate clinician burnout, improve patient monitoring, and enhance adherence to prescribed treatment protocols.

Technological investment is equally critical. Ensuring the consistent functionality of essential medical equipment necessitates systematic preventive maintenance, ongoing technical support, and capital expenditure allocations for modernizing facilities. Strengthening this aspect will reduce machine downtime and enable reliable delivery of evidenced-based care in accordance with national guidelines.

This study at ORCI exemplifies how a nuanced understanding of institutional management can illuminate pathways for improving cancer care adherence in resource-constrained settings. Its findings resonate beyond Tanzania, serving as a blueprint for similar low- and middle-income countries grappling with the challenges of guideline implementation amid infrastructural and workforce deficits.

Ultimately, the fight against cervical cancer hinges not only on the existence of well-crafted treatment guidelines but also on the robustness of healthcare delivery systems underpinning their application. Institutional leadership, organizational culture, workforce adequacy, and technological reliability converge to determine the efficacy of guideline compliance and, by extension, patient outcomes. The ORCI case study presents a compelling call to action, emphasizing that comprehensive institutional strengthening must accompany policy initiatives to drive tangible improvements in cancer care.

As the global health community intensifies efforts to reduce the cervical cancer burden, integrating management science with clinical oncology emerges as a strategic imperative. Future research avenues might explore implementation science frameworks tailored to oncology settings, evaluating interventions designed to enhance institutional capacity and resource allocation.

In the Tanzanian context, scaling these insights into national policy could catalyze a transformation in cancer care. Leveraging the lessons from ORCI, national programs might institutionalize mechanisms for continuous professional development, enforce compliance monitoring, and foster multisectoral partnerships to bolster infrastructure and human resources.

The broader implications extend into global health equity discourses, where advancing cancer care in lower-resource settings represents a critical frontier. Studies like this underscore that the path to improving cancer outcomes is multifaceted—requiring not only biomedical innovation but also strategic investment in health systems strengthening and management excellence.

In conclusion, the intersection of effective institutional management and adherence to National Cancer Treatment Guidelines is pivotal in elevating cervical cancer care standards. Addressing barriers such as personnel shortages and equipment reliability within a framework of dedicated policy and support mechanisms can significantly enhance treatment outcomes. The Ocean Road Cancer Institute’s experience offers a valuable roadmap for policymakers, clinicians, and global health stakeholders aiming to bridge the gap between guideline formulation and clinical practice in cancer care worldwide.

Subject of Research: Institutional management factors influencing compliance with National Cancer Treatment Guidelines for cervical cancer care at the Ocean Road Cancer Institute, Tanzania.

Article Title: Institutional management factors influencing compliance with National Cancer Treatment Guidelines for cervical cancer: a case study from Ocean Road Cancer Institute, Tanzania.

Article References:
Tupa, F., Ruwaichi, T., Luoga, P. et al. Institutional management factors influencing compliance with National Cancer Treatment Guidelines for cervical cancer: a case study from ocean road cancer institute, Tanzania. BMC Cancer 25, 1259 (2025). https://doi.org/10.1186/s12885-025-14702-y

Image Credits: Scienmag.com

DOI: https://doi.org/10.1186/s12885-025-14702-y